No Detail Found!

Neuro-ophthalmic interface: Investigating the therapeutic potential of Glial cell- derived neurotrophic factor (GDNF) in pathology of diabetic retinopathy

Author(s)
Durga Devi Departments of Pathology, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Moeed Ullah Khan Departments of Pathology, Nowshera Medical College, Nowshera, Pakistan
Naeemullah Syed Departments of Pathology, Federal Postgraduate Medical Institute Lahore, Pakistan
Zain ul Abden Bilal Ahmed Departments of Pathology, Liaqat Institute of Medical and Health Science, Thatta, Pakistan
Abdul Munim Departments of Pathology,Peshawar Medical College, Peshawar, Pakistan
Ehsan Khan Departments of Pathology, Allied Health Sciences Academy Lahore, Pakistan
Abstract
Objective: To investigate the therapeutic potential of Glial cell-derived neurotrophic factor (GDNF) in managing diabetic retinopathy (DR) by exploring its neuroprotective effects on retinal cells and its ability to mitigate disease progression. Methodology: This study involved 150 subjects (68 male, 82 female) including 34 healthy controls and 116 patients with DR, enrolled from OPDs and clinical care settings with mean age of 53±6.7 years. Plasma samples were subjected to Enzyme linked Immunosorbent Assay for the determination of GDNF levels. HbA1c (%) and Fasting Glucose levels (mmol/L) were used as confounders. Statistical analyses were done via SPSS 26 (T-test, significance value p<0.05). Results:  Mean GDNF level in the DR patients (4.60±2.06 µg/ml) was found significantly lower as compared to healthy controls (12.50±4.64 µg/ml) indicating that lower GDNF levels are associated with DR. HbA1c (%) and Fasting glucose were 10.49±1.12 (%) and 8.03±0.52 (mmol/L), respectively. Conclusion:  Lower GDNF levels were associated with DR, highlighting its pathological role, and confirming GDNF recovery levels as a therapeutic target to DR. 
Publication Details
Page(s) 1-4
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Diabetic retinopathy, Glial cell-derived neurotrophic factor., neuropathology
References
Yau JW,Rogers SL,Kawasaki R,Lamoureux EL,Kowalski JW,Bek T .2012 .Global prevalence and major risk factors of diabetic retinopathy. Diabetes care, 35 : 556-64.
Stewart MW .2016 .Treatment of diabetic retinopathy: Recent advances and unresolved challenges. World J Diabetes, 7 : 333-41.
Numata T,Takahashi E,Nakano N,Furuhashi M,Tada K,Nakano H .2017 .GDNF heterozygosity and brain volumes in schizophrenia. Schizophr Bull, 43 : 684-94.
Liu Y,Tao L,Fu X,Zhao Y,Xu X. .2013 .BDNF protects retinal neurons from hyperglycemia through the TrkB/ERK/MAPK pathway. Mol Med Rep, 7 : 1773-8.
Deinhardt K,Chao MV .2014 .Trk receptors. Handb Exp Pharmacol, 220 : 103-19.
Huang EJ,Reichardt LF .2003 .Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem, 72 : 609-42.
Bek T. .2020 .Systemic factors for the progression of diabetic retinopathy. Curr Diabetes Rev, 16 : 434-437.
Parisi V,Oddone F,Roberti G,Vanni G,Centofanti M,Tanga L .2020 .Neurotrophic factors, and optic neuropathy. Int J Mol Sci, 21 : 6394-8.
Liu J,Copland DA,Horie S,Wu W-K M,Xu Y .2020 .The role of MIF in age-related macular degeneration and diabetic retinopathy. Br J Ophthalmol, 104 : 538-44.
Simo-Servat O,Hernandez C,Simo R .2019 .Diabetic retinopathy in the context of patients with diabetes. Ophthalmic Res, 62 : 211-7.
Huang W,Fileta J,Dobberfuhl A,Filippopoulos T,Guo Y,Kwon G .2017 .BDNF protects against retinal ganglion cell dysfunction and loss in a rat model of glaucoma. Invest Ophthalmol Vis Sci, 58 : 405-414.
Sharma S,Taliyan R .2020 .Neuroprotective role of combined therapy of melatonin and GDNF in STZ induced experimental dementia. Neurochem Int, 135 : 104691.
Gupta VK,You Y,Gupta VB,Klistorner A,Graham SL .2013 .TrkB receptor signaling: implications in neurodegenerative, psychiatric and proliferative disorders. Int J Mol Sci, 14 : 10122-42.
Bai Y,Xu Y,Wu X,Song W,Liu T .2021 .Role of brain-derived neurotrophic factor in diabetic retinopathy: A comprehensive review. Biomed Pharmacother, 137 : 111235.
Ward MS,Jobling AI,Kolic M,Millard M,Fowler CJ,Phipps JA .2017 .Brain-derived neurotrophic factor overexpression limits retinal oxidative stress and vascular pathology in a model of diabetic retinopathy. Invest Ophthalmol Vis Sci, 58 : 3060-7.
Simó R,Stitt AW,Gardner TW .2018 .Neurodegeneration in diabetic retinopathy: does it really matter. Diabetologia, 61 : 1902-12.
Pugazhenthi S,Qin L,Reddy PH .1863 .Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochimica et biophysica acta (BBA)-molecular bas dis, : 1037-45.
Yang JY,Chen JC,Liu MY,Zhao Y,Hou J,Zheng Z .2018 .Combined application of GDNF and PEDF could improve the therapeutic effect on diabetic retinopathy. J Mol Neurosci, 64 : 402-11.
Nian S,Lo AC,Mi Y,Ren K,Yang D .2021 .Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye Vision, 8 : 15-8.
0

Citations

0

Downloads

25

Views